Maryam Keshtkar-Jahromi, MD, MPH

Primary Academic Title

Associate Professor of Medicine

Background

Lab Website

Maryam Jahromi Lab

• The Maryam Jahromi Lab researches infectious diseases such as influenza, tuberculosis, endocarditis, viral hemorrhagic fevers, brucellosis, Clostridium difficile and Crimean-Congo hemorrhagic fever. We are particularly interested in the impact of the influenza vaccine on systemic inflammation. Recent areas of focus include the relationship between influenza vaccination and cardiovascular outcomes, the emergence of Crimean-Congo hemorrhagic fever in Iran, and prospects for vaccines and therapies for Crimean-Congo hemorrhagic fever.

PubMed - Publications

http://www.ncbi.nlm.nih.gov/pubmed/?term=Keshtkar-Jahromi%20M%5BAuthor%5D&cauthor=true&cauthor_uid=18434934

Selected Publications

• Keshtkar-Jahromi M, Argani H, Rahnavardi M, Mirchi E, Atabak S, Tara SA, Gachkar L, Noori-Froothghe A, Mokhtari-Azad T. Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: a controlled trial. Am J Nephrol. 2008; 28(4): 654-60.

• Keshtkar-Jahromi M, Kuhn JH, Christova I, Bradfute SB, Jahrling PB, Bavari S. Crimean-Congo hemorrhagic fever: Current and future prospects of vaccines and therapies. Antiviral Res. 2011; 90(2): 85-92. 

• Keshtkar-Jahromi M, Sajadi Mohammad M, Ansari H, Mardani M, Holakouie Naieni K. Crimean-Congo hemorrhagic fever in Iran. Antiviral Res. 2013; 100(1): 20-8. 

• Keshtkar-Jahromi M, Sajadi Mohammad M, Ansari H, Mardani M, Holakouie Naieni K. Crimean-Congo hemorrhagic fever in Iran. Antiviral Res. 2013; 100(1): 20-8. 

• Keshtkar-Jahromi M, Vakili H, Rahnavardi M, Gholamin S, Razavi SM, Eskandari A, Sadeghi R, Vatan-Pour H, Keshtkar-Jahromi M, Haghighat B, Ghaffaripour M, Mokhtari-Azad T. Antibody response to influenza immunization in coronary artery disease patients: A controlled trial. Vaccine. 2009; 28(1): 110-3.

• Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K. Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev. 2015; 5.

• Mardani M, Keshtkar-Jahromi M, Ataie B, Adibi P. Report of Crimean Congo Hemorrhagic Fever Virus as a Nosocomial Pathogen in Iran. Am J Trop Med Hyg. 2009; 81(4): 675-8.

• Mardani M., Keshtkar-Jahromi M., Holakouie Naieni K. and Zeinali M. The Efficacy of Oral Ribavirin in the Treatment of Crimean-Congo Hemorrhagic Fever in Iran. Clin Infect Dis. 2003; 36(12): 1613-8.

• Sharifi-Mood B, Mardani M, Keshtkar-Jahromi M, Rahnavardi M, Hatami H, Metanat M. Clinical and epidemiologic features of Crimean-Congo hemorrhagic fever among children and adolescents from southeastern Iran. Pediatr Infect Dis J. 2008; 27(6): 561-3. 

• Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, Cannon CP. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013; 310(16): 1711-20.